World's Best Scientists 2026 revealed!
James E. Tcheng

James E. Tcheng

D-Index & Metrics

Medicine

D-Index
94
Citations
31850
World Ranking
10499
National Ranking
5404

Research.com Recognitions

  • 2018 - Distinguished Service Award, American College of Cardiology (ACC)

Overview

James E. Tcheng is affiliated with Duke University in the United States and conducts research primarily in the field of Medicine, with a specific focus on Cardiology and Cardiovascular Medicine, Biomedical Engineering, Surgery, Public Health, Environmental and Occupational Health, and Economics and Econometrics.

Their recent scholarly contributions include:

  • Telehealth transformation: COVID-19 and the rise of virtual care, 2020, Journal of the American Medical Informatics Association
  • Systematic review of current natural language processing methods and applications in cardiology, 2021, Heart
  • Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions, 2023, JACC: Cardiovascular Interventions
  • Determining the Suitability of Registries for Embedding Clinical Trials in the United States: A Project of the Clinical Trials Transformation Initiative, 2020, Therapeutic Innovation & Regulatory Science
  • Advancing the Real-World Evidence for Medical Devices through Coordinated Registry Networks, 2022, BMJ Surgery Interventions & Health Technologies

Their work covers several main topics, most notably:

  • Quality and Safety in Healthcare
  • Biomedical and Engineering Education
  • Artificial Intelligence in Healthcare and Education
  • Health Systems, Economic Evaluations, Quality of Life
  • Electronic Health Records Systems
  • Peripheral Artery Disease Management
  • Coronary Interventions and Diagnostics

Tcheng frequently publishes in venues such as:

  • BMJ Surgery Interventions & Health Technologies
  • Medical Devices Evidence and Research
  • International Journal of Translational Medical Research and Public Health
  • Journal of Vascular Surgery
  • Journal of the American College of Cardiology

The scientist has collaborated on multiple occasions with coauthors including Jens Eldrup-Jørgensen, Joseph P. Drozda, Philip P. Goodney, Gregory Pappas, and Jove Graham.

In 2018, James E. Tcheng received the Distinguished Service Award from the American College of Cardiology (ACC).

Best Publications

  • Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.

    Gregg W. Stone;Cindy L. Grines;David A. Cox;Eulogio Garcia

  • Telehealth transformation: COVID-19 and the rise of virtual care.

    Jedrek Wosik;Marat Fudim;Blake Cameron;Ziad Gellad;Ziad Gellad

  • 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)

    Karen A. Hicks;James E. Tcheng;Biykem Bozkurt;Bernard R. Chaitman

  • Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.

    Giuseppe De Luca;Harry Suryapranata;Gregg W. Stone;David Antoniucci

  • 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

    Karen A. Hicks;Kenneth W. Mahaffey;Roxana Mehran;Steven E. Nissen

  • Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.

    Amir Halkin;Mandeep Singh;Eugenia Nikolsky;Cindy L. Grines

  • Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.

    Paul Sorajja;Bernard J Gersh;David A Cox;Michael G McLaughlin

  • Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

    J E Tcheng;S G Ellis;B S George;D J Kereiakes

  • Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade With Percutaneous Coronary Intervention

    Eric J. Topol;James J. Ferguson;Harlan F. Weisman;James E. Tcheng

  • Impact of Renal Insufficiency in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction

    H. Mehrdad Sadeghi;Gregg W. Stone;Cindy L. Grines;Roxana Mehran

  • Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention Results of the GOLD (AU-Assessing Ultegra) Multicenter Study

    Steven R. Steinhubl;J. David Talley;Gregory A. Braden;James E. Tcheng

  • Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

    Lincoff Am;Califf Rm;Moliterno Dj;Ellis Sg

  • Clinical Outcomes of Therapeutic Agents That Block the Platelet Glycoprotein IIb/IIIa Integrin in Ischemic Heart Disease

    David F. Kong;Robert M. Califf;Dave P. Miller;David J. Moliterno

  • Restenosis after coronary angioplasty: An overview

    Robert M. Califf;Donald F. Fortin;David J. Frid;William R. Harlan

  • Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Platelet Integrin Glycoprotein IIb/IIIa Blocker Integrelin in Elective Coronary Intervention

    James E. Tcheng;Robert A. Harrington;Kandice Kottke-Marchant;Neal S. Kleiman

  • Results of prevention of REStenosis with tranilast and its outcomes (PRESTO) trial

    David R. Holmes;Michael Savage;J. M. LaBlanche;Lars Grip

  • Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease: Consensus Definitions From Peripheral Academic Research Consortium (PARC)

    Manesh R. Patel;Michael S. Conte;Donald E. Cutlip;Nabil Dib

  • Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction.

    James E. Tcheng;John D. Jackman;Charlotte L. Nelson;Laura H. Gardner

  • Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.

    Eugenia Nikolsky;Eve D. Aymong;Amir Halkin;Cindy L. Grines

  • Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication.

    Topol Ej;Ferguson Jj;Weisman Hf;Tcheng Je

Frequent Co-Authors

Robert M. Califf
Robert M. Califf Duke University
Gregg W. Stone
Gregg W. Stone Icahn School of Medicine at Mount Sinai
Roxana Mehran
Roxana Mehran Icahn School of Medicine at Mount Sinai
David A. Cox
David A. Cox University of Alabama at Birmingham
Eulogio García
Eulogio García Hospital Clínico San Carlos
Alexandra J. Lansky
Alexandra J. Lansky Yale University
Eric J. Topol
Eric J. Topol Scripps Research Institute
Cindy L. Grines
Cindy L. Grines Wayne State University
Giulio Guagliumi
Giulio Guagliumi ASST Papa Giovanni XXIII Hospital
A. Michael Lincoff
A. Michael Lincoff Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA offers diverse pathways beyond traditional doctor training. Many students consider online medical coding classes with financial aid, which prepare graduates for in-demand roles in hospitals or clinics while offering flexible learning options and support to manage costs.

Nursing is another popular field. Some aspiring nurses want to avoid extensive entrance exams, making nursing schools that don't require teas or hesi a top choice. This opens doors for those ready to jump into clinical training without added testing barriers.

For those interested in the business side of healthcare, earning a health care administration degree online can lead to management positions. These programs are perfect for working professionals aiming to advance their careers at their own pace.

Registered nurses looking to grow can explore adn to np bridge programs, which fast-track the journey from an associate degree to a master’s level nurse practitioner role.

These online degree options provide accessible entry points into healthcare careers, allowing students to find the right balance between flexibility, cost, and professional goals.

Best Scientists Citing James E. Tcheng

Trending Scientists

Recently Published Articles